RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.
A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
- Chemical Identification
- Environmental Hazards
- First Aid/Medical Treatment
- Handling/Storage/Shipping/Waste Management
- Personal Protection
- Physical Hazards/Corrective Response Actions
- Physical/Chemical Properties
- Report Abstracts and Studies
- Reproductive Risk
- Toxicology/Health Hazards/Exposure
|Example of Acute Exposure data from MEDITEXT.|
RightAnswer Proprietary Data Sources:
Other Government Links Searched via RegsKnowledge:
State Environmental Regulations
Example Content from MEDITEXT for Primaquine:
Please note: this is an extract of information from a larger document. Full document and details are available by subscription.
ACUTE EXPOSURE INFORMATION
- USES: An antimalarial agent, effective as a tissue schizonticide, indicated for the radical cure (prevention of relapse) of vivax malaria.
- PHARMACOLOGY: Primaquine is an 8-aminoquinoline compound that eliminates exoerythrocytic (tissue) infection, thereby preventing the development of the erythrocytic forms of the parasite responsible for relapses in vivax malaria.
- TOXICOLOGY: Primaquine is an oxidizing agent that can cause methemoglobinemia or hemolytic anemia, especially in susceptible populations.
- EPIDEMIOLOGY: Primaquine overdose is rare in the United States, but may be common in areas where malaria is endemic.
- WITH THERAPEUTIC USE
- COMMON: Nausea, vomiting, and abdominal cramps are frequently reported with primaquine therapy.
- WITH POISONING/EXPOSURE
- MILD TO MODERATE TOXICITY: Nausea, abdominal pain, and headaches have occurred at doses of 60 to 240 mg/day.
- SEVERE TOXICITY: Hematologic effects, including methemoglobinemia, hemolytic anemia, leukopenia, and granulocytopenia, have been reported following high doses of primaquine.
© 2011-2021 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.